Literature DB >> 34532084

Construction and evaluation of prognostic models for esophageal cancer patients with distant and non-distant metastases: providing a reference process for clinical diagnosis and treatment.

Mingxin Zhang1,2, Manli Cui1, Qianqian Zuo3, Li Wang4, Jia Wang1, Lin Zhu1, Rong Yan1, Ning Lu1, Honglin Yan1, Lingmin Zhang5.   

Abstract

BACKGROUND: Although the current treatment for esophageal cancer has great technological progress, the 5-year survival rate of patients is not optimistic. About 70% of patients with esophageal cancer are at an advanced stage at first diagnosis. These patients are prone to distant metastasis, and the prognosis is poor. Therefore, understanding the risk factors for distant metastasis in patients with esophageal cancer, combined with the prognosis of the patient, can aid in choosing the optimal diagnosis and treatment plan. Ultimately, it will improve the patient's survival time and quality of life. This research aims to construct a model for the risk assessment of distant metastasis in patients with esophageal cancer and prognostic models for patients with distant and non-distant metastases.
METHODS: The Surveillance Epidemiology and End Results (SEER) database was used to select patients with esophageal cancer from 2010 to 2015. The optimal cutoff point was selected for the age and tumor size variables using X-tile. The nomogram was constructed using R software (The R Foundation for Statistical Computing).
RESULTS: Gender, grade, T stage, N stage, and tumor size were independent risk factors associated with distant metastasis in patients with esophageal cancer. The concordance index (C-index) of the nomogram prediction model for whether the patient will have distant metastasis was 0.609. Age, grade, T stage, N stage, and tumor size were independent risk factors affecting the prognosis without distant metastasis. The C-index of the nomogram prediction model for patients with distant metastases was 0.590. Age and T stage were independent risk factors affecting the prognosis of patients with distant metastases. The C-index of the nomogram prediction model was 0.543. The combination of radiotherapy, chemotherapy, and primary surgery yielded the best overall survival for both patients with distant metastases and patients with non-distant metastases.
CONCLUSIONS: A comprehensive assessment of the risk of distant metastasis in patients with esophageal cancer, combined with prognosis prediction, is necessary to provide patients with a reasonable treatment plan. 2021 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  Esophageal cancer; distant metastasis; nomogram

Year:  2021        PMID: 34532084      PMCID: PMC8421894          DOI: 10.21037/jgo-21-429

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  21 in total

Review 1.  Evidence-based guideline recommendations on the use of positron emission tomography imaging in oesophageal cancer.

Authors:  R Wong; C Walker-Dilks; A Raifu
Journal:  Clin Oncol (R Coll Radiol)       Date:  2011-09-29       Impact factor: 4.126

2.  Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.

Authors:  Hui Wang; Feiyan Deng; Qian Liu; Yuqing Ma
Journal:  Pathol Res Pract       Date:  2017-02-03       Impact factor: 3.250

3.  X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

Authors:  Robert L Camp; Marisa Dolled-Filhart; David L Rimm
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

4.  Tumour length is an independent prognostic factor of esophageal squamous cell carcinomas.

Authors:  Ning Wu; Lie-wen Pang; Zhi-ming Chen; Qin-yun Ma; Gang Chen
Journal:  Chin Med J (Engl)       Date:  2012-12       Impact factor: 2.628

5.  Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy.

Authors:  Yizhou Wang; Jun Li; Yong Xia; Renyan Gong; Kui Wang; Zhenlin Yan; Xuying Wan; Guanghua Liu; Dong Wu; Lehua Shi; Wanyee Lau; Mengchao Wu; Feng Shen
Journal:  J Clin Oncol       Date:  2013-01-28       Impact factor: 44.544

6.  ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.

Authors:  Nicholas J Shaheen; Gary W Falk; Prasad G Iyer; Lauren B Gerson
Journal:  Am J Gastroenterol       Date:  2015-11-03       Impact factor: 10.864

7.  Which factors are associated with extremely short-term survival after surgery in patients with esophageal squamous cell carcinoma?

Authors:  Jingeng Liu; Zhiru Wei; Jun Zhang; Wei Hu; Zhenfei Ma; Qinghang Liu
Journal:  Asia Pac J Clin Oncol       Date:  2016-05-25       Impact factor: 2.601

8.  Healthcare utilization and total costs of care among patients with advanced metastatic gastric and esophageal cancer.

Authors:  Pranav Abraham; Liya Wang; Zhengzheng Jiang; Joseph Gricar; Hiangkiat Tan; Ronan J Kelly
Journal:  Future Oncol       Date:  2020-09-30       Impact factor: 3.404

9.  Treatments and outcomes of older patients with esophageal cancer: Comparison with younger patients.

Authors:  Yoshifumi Matsumoto; Kazuyoshi Kimura; Qiliang Zhou; Kenta Sasaki; Takuro Saiki; Masato Moriyama; Yasuo Saijo
Journal:  Mol Clin Oncol       Date:  2019-08-09

10.  A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma.

Authors:  Mengmeng Wang; Yuzhen Gao; Huijuan Feng; Elisa Warner; Mingrui An; Jian'an Jia; Shipeng Chen; Meng Fang; Jun Ji; Xing Gu; Chunfang Gao
Journal:  Cancer Med       Date:  2018-02-23       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.